LUNG.NASDAQPulmonx CORP

Form 4: Pulmonx Corp CFO Mehul Joshi Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Chief Financial Officer of Pulmonx Corp, Mehul Joshi, reports the acquisition of restricted stock units and stock options.

Summary

  • On May 6, 2024, Mehul Joshi, CFO of Pulmonx Corp, reported the acquisition of 125,870 shares of common stock through a Restricted Stock Unit (RSU) award.
  • These RSUs vest 25% on March 3, 2025, and the remaining portion vests in equal quarterly installments over the following three years.
  • Joshi also acquired options to purchase 241,409 shares of common stock at an exercise price of $9.28.
  • These options vest 25% on March 3, 2025, with the remainder vesting in equal monthly installments over the subsequent three years.
  • Following these transactions, Joshi directly owns 125,870 shares of common stock and options for 241,409 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, suggesting confidence in the company's future performance. The vesting schedule indicates a long-term commitment from the CFO.

Positives

  • The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the CFO.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Comparison to Industry Standards

  • Stock option and RSU grants are common compensation practices for executives in publicly traded companies, particularly in the biotech and medical device industries.
  • Vesting schedules are also standard, typically ranging from three to four years to incentivize long-term performance.

Stakeholder Impact

  • The grant of equity to the CFO can align his interests with those of shareholders, potentially leading to better company performance.
  • Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/06/2024Date of transaction: Grant of Restricted Stock Units and stock options.
03/03/2025First vesting date for both RSUs and stock options (25%).
05/05/2034Expiration date for the employee stock options.
05/07/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.